Maximilian Merz

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Maximilian Merz
Mar 29, 2025, 04:16 | Blog
Maximilian Merz: From a student to academic physician - A 14-Year Journey at MSKCC
Maximilian Merz, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post on…
Feb 25, 2025, 08:29 | Science
Maximilian Merz: What is the biology behind CAR+ T-cell lymphomas?
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared an…
Feb 23, 2025, 14:25 | Science
Myeloma Paper of the Day, February 23rd, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson…
Jan 19, 2025, 22:11 | Insight
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Jan 18, 2025, 11:00 | Science
Myeloma Paper of the Day, January 18th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: International multi-center observational study…
Jan 15, 2025, 13:17 | Science
Myeloma Paper of the Day, January 15th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Long-term follow-up of Phase…
Jan 14, 2025, 08:20 | Science
Nico Gagelmann: GSI: myeloma - cold case closed?
Nico Gagelmann, Co-founder of the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee,…
Dec 12, 2024, 13:36 | Insight
Nico Gagelmann: Tandem transplant for myeloma patients with sub-optimal responses to induction therapy
Nico Gagelmann, Co-founder and Co-chair the European Society for Blood and Marrow Transplantation (EBMT) Trainee…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Oct 31, 2024, 06:01 | Insight
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X: “Finally out!…
Oct 24, 2024, 15:45 | Blog
Myeloma Paper of the Day, October 24th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Paper of the Day: Bispecific antibodies as bridging to BCMA…
Oct 20, 2024, 09:50 | Positive
4th Annual IMS Translational Research Award Winners: Part 1
The International Myeloma Society (IMS) and the Paula and Rodger Riney Foundation have announced the fourth annual IMS Translational Research…
Oct 17, 2024, 01:11 | Societies
Highlights from DGHO24
The 2024 Annual Meeting of the German, Austrian, and Swiss Societies for Hematology and Medical…
Oct 15, 2024, 14:04 | Blog
Nico Gagelmann: Young hematologists and oncologists at DGHO24
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) shared on X: "Young hematology…
Sep 18, 2024, 14:06 | Blog
Maximilian Merz: A comeback of checkpoint inhibition in Multiple Myeloma
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared a…
Sep 16, 2024, 14:25 | Blog
Maximilian Merz: A comeback of checkpoint inhibition in Multiple Myeloma
Maximilian Merz shared a post on LinkedIn: "Please check my latest article in Nature Cancer on…
Aug 8, 2024, 10:11 | Blog
Nico Gagelmann: Fast and furious: CAR-T cells in multiple myeloma
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at The…
Apr 24, 2024, 18:36 | Blog
Maximilian Merz: Smells like team spirit
Maximilian Merz, Head of Early Clinical Trials at the Leipzig University, shared a post on…
All: 18 Posts: 1 - 100
Special Coverage